Document is current
Any future updates will be listed below
-
Authors
Nishioka, Masaki https://orcid.org/0000-0003-0845-9185
Sakashita-Kubota, Mie
Iijima, Kouichirou https://orcid.org/0000-0002-3576-5797
Hasegawa, Yukako
Ishiwata, Mizuho
Takase, Kaito
Ichikawa, Ryuya
Mechawar, Naguib https://orcid.org/0000-0003-4960-756X
Turecki, Gustavo https://orcid.org/0000-0003-4075-2736
Kato, Tadafumi https://orcid.org/0000-0001-7856-3952
-
Funding
Funding for this research was provided by:
Japan Agency for Medical Research and Development (JP24tm0424229)
Japan Agency for Medical Research and Development (JP24tm0424224)
Japan Agency for Medical Research and Development (JP25wm0625323)
MEXT | Japan Science and Technology Agency (JPMJFR231W)
MEXT | Japan Society for the Promotion of Science (JP21K07528)
MEXT | Japan Society for the Promotion of Science (JP22H00468)
- License Information
-
More Information
Article History
Received: 6 March 2025
Accepted: 17 December 2025
First Online: 7 January 2026
Competing interests
: M.N., M.S.-K., and T.K. are affiliated with the Department of Molecular Pathology of Mood Disorders at Juntendo University Graduate School of Medicine, with funding provided by Sumitomo Pharma Co. Ltd. Sumitomo Pharma Co. Ltd. had no control over the interpretation, writing, or publication of this work. K.I. is also affiliated with TechnoPro, Inc., a research assistance company. TechnoPro had no control over the interpretation, writing, or publication of this work.
